RBM15, another component of the m6A writer complex, is linked to myeloid leukemia as well where AML initiation is mediated by a chromosomal translocation t (1;22) of RBM15 (also called OTT1) with the myelin and lymphocyte (MAL) gene [45]. Here, RBM15 is linked to myeloid leukemia.